Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FYN promotes mesenchymal phenotypes of basal type breast cancer cells through STAT5/NOTCH2 signaling node
Ga-Hang Lee, Ki-Chun Yoo, Yoojeong An, et al.
Oncogene (2018) Vol. 37, Iss. 14, pp. 1857-1868
Closed Access | Times Cited: 58

Showing 26-50 of 58 citing articles:

FYN/TOPK/HSPB1 axis facilitates the proliferation and metastasis of gastric cancer
Sanfei Peng, Yuhan Yin, YiZheng Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 9
Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies
María Belén Garcia-Fabiani, Santiago Haase, Andrea Comba, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
Notch signaling in female cancers: a multifaceted node to overcome drug resistance
Maria Valeria Giuli, Angelica Mancusi, Eugenia Giuliani, et al.
Cancer Drug Resistance (2021)
Open Access | Times Cited: 18
Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women
Olfat Shaker, Mahmoud A. Senousy
Clinical Breast Cancer (2018) Vol. 19, Iss. 1, pp. e220-e238
Closed Access | Times Cited: 22
Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma
Feng Xue, Yong Jia, Jian Zhao
Surgical Oncology (2020) Vol. 33, pp. 108-117
Closed Access | Times Cited: 18
Notch-Inflammation Networks in Regulation of Breast Cancer Progression
Yulia Liubomirski, Adit Ben‐Baruch
Cells (2020) Vol. 9, Iss. 7, pp. 1576-1576
Open Access | Times Cited: 16
Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor
Mona A. Abu El-Makarem, Mariana Fathy Kamel, Ahmed Abdelhaleem Mohamed, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0277266-e0277266
Open Access | Times Cited: 9
Functional Gene Expression Differentiation of the Notch Signaling Pathway in Female Reproductive Tract Tissues—A Comprehensive Review With Analysis
Magdalena Orzechowska, Dorota Anusewicz, Andrzej K. Bednarek
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 13
Novel miR-5088-5p promotes malignancy of breast cancer by inhibiting DBC2
Hyun Jeong Seok, Young Eun Choi, Jae Yeon Choi, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 127-142
Open Access | Times Cited: 11
GNAi2/gip2-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer
Ji Hee Ha, Muralidharan Jayaraman, Mingda Yan, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1211-1211
Open Access | Times Cited: 11
Fyn-Mediated Paxillin Tyrosine 31 Phosphorylation Regulates Migration and Invasion of Breast Cancer Cells
Ying Zhang, Huanyu Zheng, Ming Xu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15980-15980
Open Access | Times Cited: 4
CD3ζ-Mediated Signaling Protects Retinal Ganglion Cells in Glutamate Excitotoxicity of the Retina
Rui Du, Ping Wang, Ning Tian
Cells (2024) Vol. 13, Iss. 12, pp. 1006-1006
Open Access | Times Cited: 1
STAT5: From Pathogenesis Mechanism to Therapeutic Approach in Acute Leukemia
Mohammad Shahjahani, Amirreza Abroun, Najmaldin Saki, et al.
Laboratory Medicine (2019) Vol. 51, Iss. 4, pp. 345-351
Closed Access | Times Cited: 11
NIBNA: a network-based node importance approach for identifying breast cancer drivers
Mandar S. Chaudhary, Vu Pham, Thuc Duy Le
Bioinformatics (2021) Vol. 37, Iss. 17, pp. 2521-2528
Closed Access | Times Cited: 10
Gene relevance based on multiple evidences in complex networks
Noemi Di Nanni, Matteo Gnocchi, Marco Moscatelli, et al.
Bioinformatics (2019) Vol. 36, Iss. 3, pp. 865-871
Open Access | Times Cited: 10
Two Sides of the Same Coin: The Role of Developmental pathways and pluripotency factors in normal mammary stem cells and breast cancer metastasis
Michael Oliphant, Deguang Kong, Hengbo Zhou, et al.
Journal of Mammary Gland Biology and Neoplasia (2020) Vol. 25, Iss. 2, pp. 85-102
Open Access | Times Cited: 10
DriverGroup: a novel method for identifying driver gene groups
Vu Pham, Lin Liu, Cameron P. Bracken, et al.
Bioinformatics (2020) Vol. 36, Iss. Supplement_2, pp. i583-i591
Open Access | Times Cited: 7
Tumor suppressing effects of tristetraprolin and its small double‐stranded RNAs in bladder cancer
Wen Jiang, Dandan Zhu, Chenghe Wang, et al.
Cancer Medicine (2020) Vol. 10, Iss. 1, pp. 269-285
Open Access | Times Cited: 6
Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia
Huizhong Xiong, Maicol Mancini, Michael Gobert, et al.
Theranostics (2020) Vol. 11, Iss. 4, pp. 1594-1608
Open Access | Times Cited: 5
The role of miR-153 and related upstream/downstream pathways in cancers: from a potential biomarker to treatment of tumor resistance and a therapeutic target
Vahab Alamdari-Palangi, Khojaste Rahimi Jaberi, Abbas Rahimi Jaberi, et al.
Medical Oncology (2022) Vol. 39, Iss. 6
Closed Access | Times Cited: 3
The Interrelationship Between FYN and miR-128/193a-5p/494 in Imatinib Resistance in Prostate Cancer
Sercan Ergün, Oğuzhan Akgün, Neslihan Hekim, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 3, pp. 360-365
Closed Access | Times Cited: 3
Screening and Identification of Key Biomarkers in Metastatic Uveal Melanoma: Evidence from a Bioinformatic Analysis
Tan Wang, Zixing Wang, Jingyuan Yang, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 7224-7224
Open Access | Times Cited: 3
Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer
Tackhoon Kim, Byung-Sun Park, Soobeen Heo, et al.
eLife (2024)
Open Access
Profiling the Expression and Prognostic Values of FYN, A Non-Receptor Tyrosine Kinase, in Different Histological Types of Epithelial Ovarian Cancer
Wiyada Dankai, Surapan Khunamornpong, Prapaporn Suprasert, et al.
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 1, pp. 321-329
Open Access | Times Cited: 1
Combinatorial CRISPR screen revealsFYNandKDM4as targets for synergistic drug combination for treating triple negative breast cancer
Tackhoon Kim, Byung-Sun Park, Soobeen Heo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Scroll to top